Side-by-side comparison of AI visibility scores, market position, and capabilities
Kyruus Health connects 500K+ providers across 1,400 hospitals and 100+ health plan brands; launched AI provider matching on AWS Bedrock with Claude 3.5 Sonnet; partnered with Healthgrades and Google Cloud in 2025.
Kyruus Health is the leading care access platform in the United States, connecting patients and health plan members to the right providers through a combination of provider data management, intelligent search, and AI-powered matching. The platform serves over 500,000 providers across 1,400 hospitals, 550 medical groups, and 100+ health plan brands — making it the de facto infrastructure for provider directory management and patient-facing provider search across much of the U.S. healthcare system. Kyruus Health''s solutions include provider directory management, consumer-facing search experiences, appointment scheduling enablement, and payer-side member engagement tools.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.